SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is trending due to reports of a looming SpaceX IPO, which has triggered a massive surge in volume and investor interest in the fund as a proxy for SpaceX exposure. The community is heavily debating the fund's valuation relative to its Net Asset Value (NAV) while aggressively comparing its SpaceX and Anthropic holdings to other venture-focused plays.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing significant downward pressure as investors speculate on potential market share loss following the launch of a private-label energy drink by Costco, though many in the community dismiss this as a temporary overreaction. The stock is currently marked by intense debate between those aggressively buying the dip, citing strong brand loyalty and long-term growth, and critics who are increasingly vocal about perceived mismanagement and concerns over declining momentum.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors weigh the stock's future amid increased regulatory scrutiny of prediction markets and ongoing NCAA trademark litigation. The community remains deeply divided, with some betting on a long-term rebound while many others are actively shorting the stock, citing persistent insider selling and stiff competition from alternative betting platforms.

Polywhale

KRILL is gaining significant social momentum as participants compare it to recent ocean-themed tokens and speculate on potential breakout patterns. Community members are actively discussing the coin's price action and broader market trends, fueling discussions about its potential for rapid growth.

ORCASM is a filthy little memecoin that knows exactly what you came for. It launched on Orca's Wavebreak but was born to make waves—wet, loud, and unforgettable. This isn’t your ordinary meme. ORCASM builds up the tension slow, goes deep, and leaves you gasping for more. It’s raw, unfiltered trencher energy dripping with shameless satisfaction. No promises. No roadmaps. Just pure, orcasmic pleasure.

Orcasm

Orcasm is capturing attention as the latest marine-themed meme coin, with community members actively coordinating to drive volume and push it into trending status. Discussions are polarized between participants celebrating significant gains and skeptical investors cautioning against potential volatility and risks associated with low-market-cap digital assets.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is facing significant volatility following a critical short report from Culper Research that alleges the company is using channel stuffing to inflate revenue, sparking intense debate among investors regarding the validity of these claims versus the company's long-term growth trajectory. While the company has officially labeled the report as misleading and speculative, the market remains divided, with some investors panic-selling over potential accounting irregularities while others are aggressively buying the dip in anticipation of a debunking and a subsequent recovery.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure as investors grow increasingly concerned about the company's aggressive capital expenditure on AI infrastructure and the long-term profitability of the Copilot platform. The community is deeply divided, with many retail traders expressing frustration over the stock's persistent underperformance and technical weakness, while others view these levels as a generational buying opportunity based on Microsoft's diversified revenue and durable market position.

Mask Network is the core product of Dimension, which is positioned to become the bridge that connects internet users from Web 2.0 to Web 3.0. The foundational technology of Mask Network is a peer-to-peer encrypted messaging application, with new functions continuously being created around this foundation. We at Mask Network are strong believers in the ownership economy. People should own what they produce, people should own their data, their attention and the virtual space they choose to contribute to.  Mask Network integrates decentralized social messaging, borderless payment network, and decentralized file storage and sharing to provide a safe and convenient portal for users to jump right into the continent of decentralized finance and then the new world of Web 3.0.

Mask Network

Mask Network is currently capturing community attention as traders highlight its low-float profile, drawing frequent comparisons to recent parabolic runners in the micro-cap space. Investors are closely monitoring the ticker for high-volatility moves while speculating on its potential to replicate the rapid gains seen in other heavily discussed small-cap assets.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently trending as investors react to a strong quarterly earnings report that featured both revenue and earnings beats, though the stock faced immediate volatility due to high market expectations. The community is sharply divided, with bulls highlighting the company's long-term potential in data center AI and physical infrastructure, while bears are emphasizing valuation concerns and the stock's recent performance relative to broader market momentum.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is seeing significant volatility as market participants debate whether recent price levels represent an oversold buying opportunity or a deeper structural risk. Community conversation is heavily focused on potential catalysts like an upcoming antitrust verdict and aggressive insider buying, fueling speculation about a possible short squeeze amid high borrowing costs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Forecasts InflaRx's Q3 Earnings (NASDAQ:IFRX)

InflaRx N.V. (NASDAQ:IFRX - Free Report) - Analysts at HC Wainwright issued their Q3 2026 EPS estimates for InflaRx in a research note issued on Thursday, March 19th. HC Wainwright analyst M. Keller...

InflaRx (NASDAQ:IFRX) Given New $14.00 Price Target at Guggenheim

Guggenheim cut their target price on InflaRx from $22.00 to $14.00 and set a "buy" rating on the stock in a research note on Friday...

Q1 Earnings Forecast for InflaRx Issued By HC Wainwright

InflaRx N.V. (NASDAQ:IFRX - Free Report) - Investment analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for InflaRx in a research note issued on Thursday, March 19th. HC Wainwright analyst M. Keller anticipates that the company will post earnings of ($0.14) per share...

InflaRx (NASDAQ:IFRX) Issues Earnings Results, Misses Expectations By $0.03 EPS

InflaRx (NASDAQ:IFRX - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.20) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by...

InflaRx N.V. (IFRX) Reports Q4 Loss, Lags Revenue Estimates

InflaRx (IFRX) delivered earnings and revenue surprises of +2.86% and -117.03%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

InflaRx (IFRX) to Release Earnings on Thursday

InflaRx (NASDAQ:IFRX) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 19. (View Earnings Report at...

InflaRx Showcases Izicopan HS and CSU Data, Streamlines C5aR Strategy at Oppenheimer Conference

InflaRx (NASDAQ:IFRX) highlighted recent clinical updates and strategic priorities for its complement inhibition platform during a presentation at Oppenheimer's 36th Annual Healthcare Life Sciences...

InflaRx Spotlights Izicopan HS Data, Phase 2b Plans and 30% Cost Cuts at Guggenheim Summit

InflaRx (NASDAQ:IFRX) highlighted progress on its oral C5a receptor 1 (C5aR) antagonist izicopan and outlined upcoming development plans during a presentation at the Guggenheim Outlook Biotech Summit...

InflaRx N.V. (NASDAQ:IFRX) Given Consensus Recommendation of "Moderate Buy" by Analysts

InflaRx N.V. (NASDAQ:IFRX - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven brokerages that are presently covering the company, MarketBeat.com reports. One research...

InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of InflaRx N.V. (NASDAQ:IFRX - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight brokerages that are currently covering the stock, MarketBeat reports. One...

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.16	--	--	N/A
Q4 '25	-$0.16	--	--	N/A
Q3 '25	-$0.21	--	--	N/A
Q2 '25	-$0.22	-$0.24	-13.19%	MISSED
Q1 '25	-$0.21	-$0.15	27.54%	BEAT

IFRX
InflaRx N.V.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest IFRX News

IFRXInflaRx N.V.